SCHEMBL19612686

SCHEMBL19612686

CCC(CC(=O)Cl)c1ccccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.43
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
CYP2D6 P10635 1/20 0.41
NFKB1 P19838 1/20 0.41
HIF1A Q16665 1/20 0.41
BLM P54132 1/20 0.41
ALDH1A1 P00352 1/20 0.40
AOC3 Q16853 1/20 0.39
KCNQ2 O43526 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NISCH Q9Y2I1 1/20 0.38
HPGD P15428 2/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ACP3 P15309 1/20 0.37
CTSA P10619 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612668 0.87 TAS1R3 (0.42) CASP1ADRB2ADRB1CYP2D6NFKB1
SCHEMBL10497400 0.86 CTSA (0.45) CASP1CTSA
SCHEMBL7323445 0.83 FEN1 (0.42) CASP1ADRB2ADRB1ALDH1A1AOC3
SCHEMBL19612663 0.83 CASP1 (0.41) CASP1ADRB2ADRB1CYP2D6NFKB1
SCHEMBL12158738 0.82 L3MBTL1 (0.55) HIF1AALDH1A1MEN1KMT2AHPGD
SCHEMBL2632968 0.81 NISCH (0.47) CASP1ADRB2ADRB1CYP2D6NFKB1
SCHEMBL11058548 0.78 MEN1 (0.45) CASP1ADRB2ADRB1CYP2D6NFKB1
SCHEMBL6175652 0.77 GABBR2 (0.47) CYP2D6KCNQ2MEN1KMT2ALMNA
SCHEMBL6173742 0.77 GABBR2 (0.47) CYP2D6KCNQ2MEN1KMT2ALMNA
SCHEMBL6173747 0.77 GABBR2 (0.47) CYP2D6KCNQ2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10174015-B2 Substituted heterocyclic derivative, preparation method and use thereof XIAMEN UNIVERSITY (CN) 2019-01-08 US disclosed
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof XIAMEN UNIVERSITY (CN) 2017-11-23 US disclosed
CN-107074788-A Substituted heterocyclic derivatives, preparation method and application thereof 厦门大学 2017-08-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof FAAH, NAAA, FAAH2 CASP1 1466/4885ADRB2 1734/4885ADRB1 1001/4885
US-10174015-B2 Substituted heterocyclic derivative, preparation method and use thereof DHPS, CYP3A5, CYP3A4 CASP1 1451/4885ADRB2 2034/4885ADRB1 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.